Research analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research note issued to investors on Wednesday. The brokerage set a “sell” rating on the stock. Ampio Pharmaceuticals Trading Down 1.7 % NYSE AMPE traded down $0.00 on Wednesday, hitting $0.22. 89,309 shares of the company traded […]
Equities research analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research report issued on Sunday. The firm set a “sell” rating on the stock. Ampio Pharmaceuticals Stock Performance About Ampio Pharmaceuticals (Get Free Report) Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of […]
StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note issued to investors on Friday. The firm issued a sell rating on the stock. Ampio Pharmaceuticals Price Performance AMPE stock opened at $0.24 on Friday. Ampio Pharmaceuticals has a 52 week low of $0.18 and a 52 week high […]
StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research note issued to investors on Saturday. The firm set a “sell” rating on the stock. Ampio Pharmaceuticals Stock Performance Ampio Pharmaceuticals Company Profile (Get Free Report) Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related […]
Research analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note issued on Monday. The firm set a “sell” rating on the stock. Ampio Pharmaceuticals Price Performance About Ampio Pharmaceuticals (Free Report) Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It […]